Latest news






Interviews



Newsletters
From the partners

21/10/21 – How the EU Pharmaceutical Strategy could help prevent the next pandemic


14/04/21 – BioVersys receives €20 million in EU financing to support development of new antibiotics

30/03/21 – Astellas and TB Alliance Enter into a New Collaborative Research Agreement to Identify Lead Compounds for the Treatment of Tuberculosis

AMR Accelerator Newsletter – November 2021
ERA4TB Newsletter – July 2021
AMR Accelerator Newsletter – May 2021
ERA4TB Newsletter – May 2021
RespiriNTM & -TB Newsletter – April 2021